Report Summary
Eternity Insights has published a new study on Global At-Home Drug Of Abuse (DOA) Testing Market focusing on key segments as by Type (Test Cups, Test Dip Cards, Test Strips, Others), by Application (Urine, Saliva, Hair, Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global At-Home Drug Of Abuse (DOA) Testing Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
At-Home Drug Of Abuse (DOA) Testing Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global At-Home Drug Of Abuse (DOA) Testing Market Size, 2018-2028 (USD Million)
To learn more about this report
Global At-Home Drug Of Abuse (DOA) Testing Market Segmentation:
At-Home Drug Of Abuse (DOA) Testing Market, By Type
- Test Cups
- Test Dip Cards
- Test Strips
- Others
At-Home Drug Of Abuse (DOA) Testing Market, By Application
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global At-Home Drug Of Abuse (DOA) Testing market in terms of demand generation. The At-Home Drug Of Abuse (DOA) Testing market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for At-Home Drug Of Abuse (DOA) Testing market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global At-Home Drug Of Abuse (DOA) Testing Market Taxonomy:
To learn more about this report
Global At-Home Drug Of Abuse (DOA) Testing Market Competitive Landscape
The global At-Home Drug Of Abuse (DOA) Testing market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- UCP Biosciences
- Orient New Life Medical
- Express Diagnostics Int�l
- Assure Tech (Hangzhou)
- Psychemedics Corporation
- Confirm BioSciences
- Phamatech
- Home Health (U.K.) Ltd.
- Quest Products
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Test Cups, Test Dip Cards, Test Strips, Others |
| By Application Outlook |
Urine, Saliva, Hair, Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
UCP Biosciences, Orient New Life Medical, Express Diagnostics Int�l, Assure Tech (Hangzhou), Psychemedics Corporation, Confirm BioSciences, Phamatech, Home Health (U.K.) Ltd., Quest Products |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 At-Home Drug of Abuse (DOA) Testing Market Overview
1.1 At-Home Drug of Abuse (DOA) Testing Product Overview
1.2 At-Home Drug of Abuse (DOA) Testing Market Segment by Type
1.2.1 Test Cups
1.2.2 Test Dip Cards
1.2.3 Test Strips
1.2.4 Others
1.3 Global At-Home Drug of Abuse (DOA) Testing Market Size by Type
1.3.1 Global At-Home Drug of Abuse (DOA) Testing Sales and Growth by Type
1.3.2 Global At-Home Drug of Abuse (DOA) Testing Sales and Market Share by Type (2017-2020)
1.3.3 Global At-Home Drug of Abuse (DOA) Testing Revenue and Market Share by Type (2017-2020)
1.3.4 Global At-Home Drug of Abuse (DOA) Testing Price by Type (2017-2020)
2 Global At-Home Drug of Abuse (DOA) Testing Market Competition by Company
2.1 Global At-Home Drug of Abuse (DOA) Testing Sales and Market Share by Company (2017-2020)
2.2 Global At-Home Drug of Abuse (DOA) Testing Revenue and Share by Company (2017-2020)
2.3 Global At-Home Drug of Abuse (DOA) Testing Price by Company (2017-2020)
2.4 Global Top Players At-Home Drug of Abuse (DOA) Testing Manufacturing Base Distribution, Sales Area, Product Types
2.5 At-Home Drug of Abuse (DOA) Testing Market Competitive Situation and Trends
2.5.1 At-Home Drug of Abuse (DOA) Testing Market Concentration Rate
2.5.2 Global At-Home Drug of Abuse (DOA) Testing Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 At-Home Drug of Abuse (DOA) Testing Company Profiles and Sales Data
3.1 UCP Biosciences
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 At-Home Drug of Abuse (DOA) Testing Product Category, Application and Specification
3.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin(2017-2020)
3.1.4 Main Business Overview
3.2 Orient New Life Medical
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 At-Home Drug of Abuse (DOA) Testing Product Category, Application and Specification
3.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin(2017-2020)
3.2.4 Main Business Overview
3.3 Express Diagnostics Int’l
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 At-Home Drug of Abuse (DOA) Testing Product Category, Application and Specification
3.3.3 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin(2017-2020)
3.3.4 Main Business Overview
3.4 Assure Tech (Hangzhou)
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 At-Home Drug of Abuse (DOA) Testing Product Category, Application and Specification
3.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin(2017-2020)
3.4.4 Main Business Overview
3.5 Psychemedics Corporation
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 At-Home Drug of Abuse (DOA) Testing Product Category, Application and Specification
3.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin(2017-2020)
3.5.4 Main Business Overview
3.6 Confirm BioSciences
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 At-Home Drug of Abuse (DOA) Testing Product Category, Application and Specification
3.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin(2017-2020)
3.6.4 Main Business Overview
3.7 Phamatech
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 At-Home Drug of Abuse (DOA) Testing Product Category, Application and Specification
3.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin(2017-2020)
3.7.4 Main Business Overview
3.8 Home Health (U.K.) Ltd.
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 At-Home Drug of Abuse (DOA) Testing Product Category, Application and Specification
3.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin(2017-2020)
3.8.4 Main Business Overview
3.9 Quest Products
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 At-Home Drug of Abuse (DOA) Testing Product Category, Application and Specification
3.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin(2017-2020)
3.9.4 Main Business Overview
4 At-Home Drug of Abuse (DOA) Testing Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global At-Home Drug of Abuse (DOA) Testing Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global At-Home Drug of Abuse (DOA) Testing Sales and Revenue by Regions
4.2.1 Global At-Home Drug of Abuse (DOA) Testing Sales and Market Share by Regions (2017-2020)
4.2.2 Global At-Home Drug of Abuse (DOA) Testing Revenue and Market Share by Regions (2017-2020)
4.2.3 Global At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2017-2020)
4.3 North America At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 At-Home Drug of Abuse (DOA) Testing Application/End Users
5.1 At-Home Drug of Abuse (DOA) Testing Segment by Application
5.1.1 Urine
5.1.2 Saliva
5.1.3 Hair
5.1.4 Others
5.2 Global At-Home Drug of Abuse (DOA) Testing Product Segment by Application
5.2.1 Global At-Home Drug of Abuse (DOA) Testing Sales by Application
5.2.2 Global At-Home Drug of Abuse (DOA) Testing Sales and Market Share by Application (2017-2020)
6 Global At-Home Drug of Abuse (DOA) Testing Market Forecast
6.1 Global At-Home Drug of Abuse (DOA) Testing Sales, Revenue Forecast (2021-2027)
6.1.1 Global At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate Forecast (2021-2027)
6.1.1 Global At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate Forecast (2021-2027)
6.2 Global At-Home Drug of Abuse (DOA) Testing Forecast by Regions
6.2.1 North America At-Home Drug of Abuse (DOA) Testing Sales and Revenue Forecast (2021-2027)
6.2.2 Europe At-Home Drug of Abuse (DOA) Testing Sales and Revenue Forecast (2021-2027)
6.2.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Sales and Revenue Forecast (2021-2027)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America At-Home Drug of Abuse (DOA) Testing Sales and Revenue Forecast (2021-2027)
6.2.5 Middle East and Africa At-Home Drug of Abuse (DOA) Testing Sales and Revenue Forecast (2021-2027)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 At-Home Drug of Abuse (DOA) Testing Forecast by Type
6.3.1 Global At-Home Drug of Abuse (DOA) Testing Sales and Revenue Forecast by Type (2021-2027)
6.3.2 Test Cups Gowth Forecast
6.3.3 Test Dip Cards Gowth Forecast
6.4 At-Home Drug of Abuse (DOA) Testing Forecast by Application
6.4.1 Global At-Home Drug of Abuse (DOA) Testing Sales Forecast by Application (2021-2027)
6.4.2 Global At-Home Drug of Abuse (DOA) Testing Forecast in Urine
6.4.3 Global At-Home Drug of Abuse (DOA) Testing Forecast in Saliva
7 At-Home Drug of Abuse (DOA) Testing Upstream Raw Materials
7.1 At-Home Drug of Abuse (DOA) Testing Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 At-Home Drug of Abuse (DOA) Testing Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
